Salivary nicotine and cotinine concentrations in unstimulated and stimulated saliva

African Journal of Pharmacy and Pharmacology

Volumn 4, Issue 2, 2010, Pages 061-065

  Robson, N ^a   Bond, A J ^b   Wolff, K ^b  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Biological marker; Cotinine; Nicotine; Oral; Passive; Saliva; Smoke; Smoker; Technique; Tobacco; Verify

Indexed keywords

COTININE; NICOTINE;

ADULT; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; HUMAN; MALE; SALIVA ANALYSIS; SALIVA LEVEL; STIMULATION;

EID: 77953654845     PISSN: None     EISSN: 19960816     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Beckett AH, Gorrod JW, Jenner P (1972). A possible relation between pKa 1 and lipid solubility and the amounts excreted in urine of some tobacco alkaloids given to man. J. Pharm. Pharmacol. 24(2): 115-20 24; 115-120.
2. Benowitz NL (1996). Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiologic Reviews 18: 188-204.
3. Ciolino LA, McCauley HA, Fraser DB, Wolnik KA (2001a). The relative buffering capacities of saliva and moist snuff: implications for nicotine absorption. J. Anal. Toxicol. 25: 15-25.
4. Ciolino LA, McCauley HA, Fraser DB, Wolnik KA (2001b). The relative buffering capacities of saliva and moist snuff: implications for nicotine absorption. J. Analytical Toxicol. 25: 15-25.
5. Curvall M, Elwin CE, Kazemi-Vala E, Warholm C, Enzell CR (1990). The pharmacokinetics of cotinine in plasma and saliva from non-smoking healthy volunteers. Eur. J. Clin. Pharmacol. 38: 281-287.
6. Dawes C (1969). The effects of flow rate and duration of stimulation on the condentrations of protein and the main electrolytes in human parotid saliva. pp. 277-294.
7. Dawes C (2005a). The unstimulated salivary flow rate after prolonged gum chewing. Arch. Oral Biol. 40(8): 699-705; 50: 561-563.
8. Dawes C (2005b). The unstimulated salivary flow rate after prolonged gum chewing. Arch. Oral Biol. 50: 561-563.
9. Dawes C, Kubieniec K (2004). The effects of prolonged gum chewing on salivary flow rate and composition. Arch. Oral Biol. 40(8): 699-705; 49: 665-669.
10. Di Giusto E, Eckhard I (1986). Some properties of saliva cotinine measurements in indicating exposure to tobacco smoking. Am. J. Public Health 76: 1245-1246.
11. Hatsukami DK, Hecht SS, Hennrikus DJ, Joseph AM, Pentel PR (2003). Biomarkers of tobacco exposure or harm: application to clinical and epidemiological studies. Minneapolis, Minnesota. Nicotine & Tobacco Research 5(3): 387-396.
12. Jarvis MJ, Primatesta P, Erens B, Feyerabend C, Bryant A (2003). Measuring nicotine intake in population surveys: comparability of saliva cotinine and plasma cotinine estimates. Nicotine & Tobacco Research 5: 349-355.
13. Jarvis MTP, Feyerabend H, Vesey C, Salloojee YC (1984). Biochemical markers of smoke absorption and self reported exposure to passive smoking. J. Epidemiol. Community Health 38: 335-339.
14. Kidwell DA, Holland JC, Athanaselis S (1998). Testing for drugs of abuse in saliva and sweat.[erratum appears in J. Chromatogr. B. Biomed. Sci. Appl. 22; 721(2): 333]. J. Chromatogr. B. Biomed. Sci. Applications 713: 111-135.
15. Liu H, Delgado MR (1999). Therapeutic drug concentration monitoring using saliva samples. Focus on anticonvulsants. Clin. Pharmacokinetics 36: 453-470.
16. Patterson F, Benowitz N, Shields P, Kaufmann V, Jepson C, Wileyto P (2003). Individual differences in nicotine intake per cigarette. 468-471.
17. Polland KE, Higgins F, Orchardson R (2003). Salivary flow rate and pH during prolonged gum chewing in humans. J. Oral Rehabil. 30: 861-865.
18. Rantonen PJ, Meurman JH (1998). Viscosity of whole saliva. Acta Odontol. Scand. 56: 210-214.
19. Schneider NG, Jacob P, Nilsson F, Leischow SJ, Benowitz NL, Olmstead RE (1997). Saliva cotinine levels as a function of collection method. Addiction 92: 347-351.
20. Torano JS, van Kan HJ (2003). Simultaneous determination of the tobacco smoke uptake parameters nicotine, cotinine and thiocyanate in urine, saliva and hair, using gas chromatography-mass spectrometry for characterisation of smoking status of recently exposed subjects. Analyst 128: 838-843.
21. U.S. Department of Health and Human Services NCfHS (1996). NHANES III reference manuals and reports (CD-ROM): Hyattsville, MD: Centers for Disease Control and Prevention.
22. Yang M, Kunugita N, Kitagawa K, Kang SH, Coles B, Kadlubar FF (2001). Individual differences in urinary cotinine levels in Japanese smokers: relation to genetic polymorphism of drug-metabolizing enzymes. Cancer Epidemiol. Biomarkers Prev. 10: 589-593.
23. Zevin S, Gourlay SG, Benowitz NL (1998). Clinical pharmacology of nicotine. Clinics in Dermatology 16: 557-564.
24. Zevin S, Jacob P, Geppetti P, Benowitz NL (2000). Clinical pharmacology of oral cotinine. Drug Alcohol Depend. 60: 13-18.